TY - JOUR
T1 - Ocular Toxoplasmosis
AU - Goh, Eunice Jin Hui
AU - Putera, Ikhwanuliman
AU - Nora, Rina La Distia
AU - Mahendradas, Padmamalini
AU - Biswas, Jyotirmay
AU - Chee, Soon-Phaik
AU - Testi, Ilaria
AU - Pavesio, Carlos E.
AU - Curi, Andre Luiz Land
AU - Vasconcelos-Santos, Daniel Vitor
AU - Arora, Atul
AU - Gupta, Vishali
AU - de-la-Torre, Alejandra
AU - Agrawal, Rupesh
N1 - Funding Information:
The author(s) reported there is no funding associated with the work featured in this article.
Publisher Copyright:
© 2022 Taylor & Francis Group, LLC.
PY - 2023
Y1 - 2023
N2 - Introduction: Ocular toxoplasmosis is the leading cause of posterior uveitis worldwide, affecting individuals acrossdifferent age groups. The key to reducing vision loss includes prompt diagnosis and treatment. However, despite the prevalence of ocular toxoplasmosis, there has been little consensus regarding its pathophysiology,clinical features, diagnosis, and especially management. Methods: The data sources were literature reviews, including Pub Med and Medline databases. Search terms included toxoplasmosis, retinitis, vasculitis, vitritis, uveitis alone or in combination with, serum, aqueous, vitreous eye, ocular and review. Results: In this review paper, we have sought to provide an overview of the pathophysiology, epidemiology, and clinical features of the disease, both based on current literature and our own clinical experience. We have also discussed the use of serology, ocular fluid, and ophthalmic investigations that could further facilitate the diagnosis of ocular toxoplasmosis.Different management strategies have been reported worldwide, including newer approaches such as local therapy. Conclusion: A better understanding of critical aspects of ocular toxoplasmosis will hopefully lead to reduced morbidity, including blindness associated with this condition.
AB - Introduction: Ocular toxoplasmosis is the leading cause of posterior uveitis worldwide, affecting individuals acrossdifferent age groups. The key to reducing vision loss includes prompt diagnosis and treatment. However, despite the prevalence of ocular toxoplasmosis, there has been little consensus regarding its pathophysiology,clinical features, diagnosis, and especially management. Methods: The data sources were literature reviews, including Pub Med and Medline databases. Search terms included toxoplasmosis, retinitis, vasculitis, vitritis, uveitis alone or in combination with, serum, aqueous, vitreous eye, ocular and review. Results: In this review paper, we have sought to provide an overview of the pathophysiology, epidemiology, and clinical features of the disease, both based on current literature and our own clinical experience. We have also discussed the use of serology, ocular fluid, and ophthalmic investigations that could further facilitate the diagnosis of ocular toxoplasmosis.Different management strategies have been reported worldwide, including newer approaches such as local therapy. Conclusion: A better understanding of critical aspects of ocular toxoplasmosis will hopefully lead to reduced morbidity, including blindness associated with this condition.
UR - https://www.scopus.com/pages/publications/85138331229
U2 - 10.1080/09273948.2022.2117705
DO - 10.1080/09273948.2022.2117705
M3 - Review article
SN - 0927-3948
VL - 31
SP - 1342
EP - 1361
JO - Ocular Immunology and Inflammation
JF - Ocular Immunology and Inflammation
IS - 7
ER -